News & Analysis as of

Continuing Resolution Legislative Agendas

Holland & Knight LLP

Holland & Knight Health Dose: March 19, 2025

Holland & Knight LLP on

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more

McDermott+

McDermott+ Check-Up: March 7, 2025

McDermott+ on

Government Funding Deadline, Healthcare Program Expirations Approach. Following recent House and Senate passage of their competing budget resolutions, Congress’ attention has now turned to the March 14, 2025, government...more

Alston & Bird

Look Ahead to the Week of March 3: Trump Addresses Congress

Alston & Bird on

Both the House and Senate are in session this week. Last week, House Republicans were able to coalesce in dramatic fashion to pass a budget resolution that creates a process to combine President Trump’s tax policy and other...more

Bergeson & Campbell, P.C.

With Less Than One Month until Election Day, a Growing List of Policy Issues Needs Attention during the Lame Duck Session

The list of pending issues that Congress could consider during the lame duck session in 2024 continues to grow. The list includes “must pass” items, including appropriations to fund the government through the remainder of...more

Bergeson & Campbell, P.C.

Congress Fails to Pass Spending Legislation, but a Shutdown Is Unlikely

Congress has not passed legislation to fund the federal government for fiscal year 2025 (FY 2025) that begins October 1, 2024. The House of Representatives on September 18 tried — and failed — to pass legislation to fund the...more

Ogletree, Deakins, Nash, Smoak & Stewart,...

Beltway Buzz - January 2024

The Beltway Buzz is a weekly update summarizing labor and employment news from inside the Beltway and clarifying how what’s happening in Washington, D.C., could impact your business....more

Ogletree, Deakins, Nash, Smoak & Stewart,...

Beltway Buzz - November 2023 #3

The Beltway Buzz is a weekly update summarizing labor and employment news from inside the Beltway and clarifying how what’s happening in Washington, D.C., could impact your business. Smackdowns and Shutdowns on Capitol...more

Holland & Knight LLP

Holland & Knight Health Dose: October 3, 2023

Holland & Knight LLP on

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector. ...more

Holland & Knight LLP

Holland & Knight Health Dose: December 13, 2022

Holland & Knight LLP on

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector. This week's topics include: ...more

Holland & Knight LLP

Holland & Knight Health Dose: December 6, 2022

Holland & Knight LLP on

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector. This week's topics include: -...more

Holland & Knight LLP

Holland & Knight Health Dose: November 15, 2022

Holland & Knight LLP on

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector. This week's topics include: ...more

Akin Gump Strauss Hauer & Feld LLP

As “Skinny” FDA User Fee Reauthorizations Cross Finish Line, Congress Prepares to Revisit FDA Policy Riders in Lame Duck Session

On September 30, 2022, Congress enacted legislation to reauthorize the Food and Drug Administration (FDA) user fee programs for branded/reference drugs and biologics, medical devices, generic drugs and biosimilars (PDUFA,...more

Holland & Knight LLP

Holland & Knight Health Dose: September 27, 2022

Holland & Knight LLP on

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector. This week's topics include: ...more

Venable LLP

The Congressional Post-Labor Day and Lame-Duck Outlook

Venable LLP on

​​​​​​​As we move past Labor Day, little time is left before both chambers leave again for the November elections. The House of Representatives is slated to be in town for only 11 days in September before breaking, and though...more

Clark Hill PLC

Window on Washington – Vol. 6, Issue 6

Clark Hill PLC on

The Senate is in session this week, and the House has a committee work period. The Senate plans to vote on nominee confirmations, on U.S. Postal Service reform legislation, and on the House-passed continuing resolution (CR)...more

Ogletree, Deakins, Nash, Smoak & Stewart,...

Beltway Buzz - December 2020 #2

Tick Tock. The clock is ticking and the 116th Congress has three big tasks in its waning days: ensure the federal government does not shut down due to a lack of funding, pass the National Defense Authorization Act, and get an...more

Mintz - ML Strategies

ML Strategies Lame Duck Update: Trade and China Tariffs

Mintz - ML Strategies on

With a dwindling number of in-session legislative days before the end of the current 116th Congress, the U.S. House of Representatives and Senate are working to conclude their work before adjourning at the end of the year....more

Akin Gump Strauss Hauer & Feld LLP

2020 Post-Election Outlook

Former Vice President Joe Biden has been elected to serve as the 46th President of the United States, crossing the 270 electoral vote threshold on Saturday, November 7, with a victory in Pennsylvania. His running mate, Sen....more

Stinson - Government Contracting Matters

So … Where’s the Money?

It’s September 24, 2020, and the 2020 fiscal year ends at the stroke of midnight on September 30th. Back in July, the House and Senate had passed their respective versions of the National Defense Authorization Act (NDAA) for...more

Brownstein Hyatt Farber Schreck

Health Extenders Overview and Outlook

On Friday, Sept. 27, President Trump signed a continuing resolution (CR) to fund the government at current levels until Nov. 21. This extended funding for the 20 health care programs that were set to expire at the end of the...more

Mintz - Health Care Viewpoints

ML Strategies Health Care Preview - September 2019 #2

Congress returns to session this week with days to pass a continuing resolution (CR) to keep the government open. The House of Representatives passed a short term bill to keep the government open through November 21st, but a...more

Mintz - Health Care Viewpoints

ML Strategies Health Care Preview - September 2019

This week, Congressional appropriators are hoping to finalize a continuing resolution (CR) that would extend funding for the government through the middle of November. The House Rules Committee will meet on Tuesday to...more

Mintz - Health Care Viewpoints

Health Care Weekly Preview from ML Strategies – December 2018 #2

This week, Congress is in session for what should be the last week of the 115th Congress. That said, best not to count your chickens before they hatch. The spending fight that has been raging since the last continuing...more

Holland & Knight LLP

Post-Election Energy and Environment Outlook for Lame-Duck Session and the 116th Congress

Holland & Knight LLP on

• Although energy and environmental issues are not expected to be among the top priorities for either party in the 116th Congress, this Holland & Knight client alert addresses several opportunities for limited bipartisan...more

Mintz - Health Care Viewpoints

February 5, 2018 Continuing Resolution: Health Care Provisions

Late Monday night (February 5, 2018), the House of Representatives released a continuing resolution to keep the government funded and running until March 23, 2018. This CR includes many health care related provisions,...more

35 Results
 / 
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide